Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|
July 17, 1999
[Peripheral nerve lesions after total hip endoprosthesis]
K Knahr, J Krugluger, U Pluschnig
International Angiology : a Journal of the International Union of Angiology
|
May 22, 2004
Oral anticoagulation in older patients with vascular or cardiovascular diseases. Aged over 70 years: same risk? Same benefit?
M Hirschl, U Pluschnig, M Kundi, et al.
Annals of Surgical Oncology
|
November 11, 2010
Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study
G Spizzo, D Öfner, A de Vries, et al.
European Radiology
|
September 14, 2011
High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
K Pinker-Domenig, W Bogner, S Gruber, et al.
The British Journal of Surgery
|
May 28, 2011
HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases
S F Schoppmann, B Jesch, J Zacherl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experience
G G Steger, R Bartsch, C Wenzel, et al.
European Radiology
|
March 19, 2013
Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions
K Pinker, H Bickel, T H Helbich, et al.
British Journal of Cancer
|
December 1, 2011
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
R Bartsch, A Berghoff, U Pluschnig, et al.
British Journal of Cancer
|
September 30, 2010
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value
A Michlmayr, T Bachleitner-Hofmann, S Baumann, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial
M Schmidinger, A C Budinsky, C Wenzel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|
July 17, 1999
[Peripheral nerve lesions after total hip endoprosthesis]
K Knahr, J Krugluger, U Pluschnig
International Angiology : a Journal of the International Union of Angiology
|
May 22, 2004
Oral anticoagulation in older patients with vascular or cardiovascular diseases. Aged over 70 years: same risk? Same benefit?
M Hirschl, U Pluschnig, M Kundi, et al.
Annals of Surgical Oncology
|
November 11, 2010
Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study
G Spizzo, D Öfner, A de Vries, et al.
European Radiology
|
September 14, 2011
High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
K Pinker-Domenig, W Bogner, S Gruber, et al.
The British Journal of Surgery
|
May 28, 2011
HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases
S F Schoppmann, B Jesch, J Zacherl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experience
G G Steger, R Bartsch, C Wenzel, et al.
European Radiology
|
March 19, 2013
Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions
K Pinker, H Bickel, T H Helbich, et al.
British Journal of Cancer
|
December 1, 2011
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
R Bartsch, A Berghoff, U Pluschnig, et al.
British Journal of Cancer
|
September 30, 2010
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value
A Michlmayr, T Bachleitner-Hofmann, S Baumann, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial
M Schmidinger, A C Budinsky, C Wenzel, et al.
Page
of 2